Interactions of iron with manganese, zinc, chromium, and selenium as related to prophylaxis and treatment of iron deficiency

Journal of Trace Elements in Medicine and Biology

Volumn 41, Issue , 2017, Pages 41-53

  Bjørklund, Geir ^a   Aaseth, Jan ^b,c   Skalny, Anatoly V ^d,e,f,g   Suliburska, Joanna ^h   Skalnaya, Margarita G ^d   Nikonorov, Alexandr A ^e,i   Tinkov, Alexey A ^d,e,f,i  

^a Council for Nutritional and Environmental Medicine ^*  (Norway)

^b Hedmark University of Applied Sciences   (Norway)

^c INNLANDET HOSPITAL TRUST   (Norway)

^d PEOPLES FRIENDSHIP UNIVERSITY OF RUSSIA   (Russian Federation)

^e ORENBURG STATE UNIVERSITY   (Russian Federation)

^f YAROSLAVL STATE UNIVERSITY   (Russian Federation)

^g All Russia Science Research Institute of Medicinal and Aromatic Plants   (Russian Federation)

^h POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

ⁱ ORENBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Chromium; Iron; Iron deficiency; Manganese; Selenium; Zinc

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CERULOPLASMIN; CHROMIUM; HEMOCHROMATOSIS PROTEIN; HEMOJUVELIN; IRON; MANGANESE; MYOGLOBIN; SELENIUM; TRACE ELEMENT; TRANSFERRIN; TRANSFERRIN RECEPTOR; ZINC;

BINDING SITE; DRUG ABSORPTION; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; IRON ABSORPTION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON OVERLOAD; IRON THERAPY; LIPID METABOLISM; MEAN CORPUSCULAR VOLUME; NONHUMAN; OLFACTORY EPITHELIUM; OXIDATION; PROTEIN BINDING; REVIEW; TISSUE DISTRIBUTION; ANEMIA, IRON-DEFICIENCY; ANIMAL; CHEMISTRY; METABOLISM;

ANEMIA, IRON-DEFICIENCY; ANIMALS; CHROMIUM; HUMANS; IRON; MANGANESE; SELENIUM; ZINC;

EID: 85013343998     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2017.02.005     Document Type: Review

References (187)

1. [1] Anderson, G.J., McLaren, G.D., Iron Physiology and Pathophysiology in Humans. 2012, Humana Press, New York.
2. [2] Kassebaum, N.J., Jasrasaria, R., Naghavi, M., Wulf, S.K., Johns, N., Lozano, R., Regan, M., Weatherall, D., Chou, D.P., Eisele, T.P., Flaxman, S.R., Pullan, R.L., Brooker, S.J., Murray, C.J., A systematic analysis of global anemia burden from 1990 to 2010. Blood 123 (2014), 615–624.
3. [3] World Health Organization, Iron Deficiency Anaemia: Assessment, Prevention, and Control. A Guide for Programme Managers. 2001, World Health Organization, Genève.
4. [4] Steinbicker, A.U., Muckenthaler, M.U., Out of balance—systemic iron homeostasis in iron-related disorders. Nutrients 5 (2013), 3034–3061.
5. [5] Food and Nutrition Board, Institute of medicine, iron. Food and Nutrition Board, Institute of Medicine, Dietary Reference Intakes for Vitamin A, Vitamin K, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, 2001, National Academy Press, Washington, 290–393.
6. [6] Pizarro, F., Yip, R., Dallman, P.R., Olivares, M., Hertrampf, E., Walter, T., Iron status with different infant feeding regimens: relevance to screening and prevention of iron deficiency. J. Pediatr. 118 (1991), 687–692.
7. [7] Black, M.M., Quigg, A.M., Hurley, K.M., Pepper, M.R., Iron deficiency and iron-deficiency anemia in the first two years of life: strategies to prevent loss of developmental potential. Nutr. Rev. 69:Suppl. 1 (2011), S64–S70.
8. [8] Domellöf, M., Iron requirements in infancy. Ann. Nutr. Metab. 59 (2011), 59–63.
9. [9] Aggett, P.J., Iron. Erdman, J.W., Macdonald, I.A., Zeisel, S.H., (eds.) Present Knowledge in Nutrition, tenth ed., 2012, Wiley-Blackwell, Washington, 506–520.
10. [10] Harvey, L.J., Armah, C.N., Dainty, J.R., Foxall, R.J., John Lewis, D., Langford, N.J., Fairweather-Tait, S.J., Impact of menstrual blood loss and diet on iron deficiency among women in the UK. Br. J. Nutr. 94 (2005), 557–564.
11. [11] Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., Loréal, O., A new mouse liver-specific gene encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276 (2001), 7811–7819.
12. [12] Hallberg, L., Rossander-Hulten, L., Brune, M., Gleerup, A., Calcium and iron absorption: mechanism of action and nutritional importance. Eur. J. Clin. Nutr. 46 (1992), 317–327.
13. [13] Lönnerdal, B., Calcium and iron absorption-mechanisms and public health relevance. Int. J. Vitam. Nutr. Res. 80 (2010), 293–299.
14. [14] Disler, P.B., Lynch, S.R., Charlton, R.W., Torrance, J.D., Bothwell, T.H., Walker, R.B., Mayet, F., The effect of tea on iron absorption. Gut 16 (1975), 193–200.
15. [15] Hallberg, L., Wheat fiber, phytates and iron absorption. Scand. J. Gastroenterol.(Suppl. 129), 1987, 73–79.
16. [16] Bloomberg, R.D., Fleishman, A., Nalle, J.E., Herron, D.M., Kini, S., Nutritional deficiencies following bariatric surgery: what have we learned?. Obes. Surg. 15 (2005), 145–154.
17. [17] Gasche, C., Berstad, A., Befrits, R., Beglinger, C., Dignass, A., Erichsen, K., Gomollon, F., Hjortswang, H., Koutroubakis, I., Kulnigg, S., Oldenburg, B., Rampton, D., Schroeder, O., Stein, J., Travis, S., Van Assche, G., Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm. Bowel Dis. 13 (2007), 1545–1553.
18. [18] Bermejo, F., Garcia-Lopez, S., A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J. Gastroenterol. 15 (2009), 4638–4643.
19. [19] Bayraktar, U.D., Bayraktar, S., Treatment of iron deficiency anemia associated with gastrointestinal tract diseases. World J. Gastroenterol. 16 (2010), 2720–2725.
20. [20] Gudzune, K.A., Huizinga, M.M., Chang, H.Y., Asamoah, V., Gadgil, M., Clark, J.M., Screening and diagnosis of micronutrient deficiencies before and after bariatric surgery. Obes. Surg. 23 (2013), 1581–1589.
21. [21] McDermid, J.M., Lönnerdal, B., Iron. Adv. Nutr. 3 (2012), 532–533.
22. [22] Hurrell, R., Egli, I., Iron bioavailability and dietary reference values. Am. J. Clin. Nutr. 91 (2010), 1461S–1467S.
23. [23] Zimmermann, M.B., Hurrell, R.F., Nutritional iron deficiency. Lancet 370 (2007), 511–520.
24. [24] Cantor, A.G., Bougatsos, C., Dana, T., Blazina, I., McDonagh, M., Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the U.S. preventive services task force. Ann. Intern. Med. 162 (2015), 566–576.
25. [25] Aaseth, J., Thomassen, Y., Ellingsen, D.G., Støa-Birketvedt, G., Prophylactic iron supplementation in pregnant women in Norway. J. Trace Elem. Med. Biol. 15 (2001), 167–174.
26. [26] Moussa, H.N., Hosseini Nasab, S., Haidar, Z.A., Blackwell, S.C., Sibai, B.M., Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks. Future Sci. OA, 2, 2016, FSO116, 10.4155/fsoa-2015-0015.
27. [27] Vulpe, C.D., Kuo, Y.M., Murphy, T.L., Cowley, L., Askwith, C., Libina, N., Gitschier, J., Anderson, G.J., Hephaestin a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21 (1999), 195–199.
28. [28] Turnlund, J.R., Copper. Shils, M.E., Shike, M., Ross, A.C., Caballero, B., Cousins, R.J., (eds.) Modern Nutrition in Health and Disease, tenth ed., 2006, Lippincott Williams & Wilkins, Philadelphia, 286–299.
29. [29] Collins, J.F., Prohaska, J.R., Knutson, M.D., Metabolic crossroads of iron and copper. Nutr. Rev. 68 (2010), 133–147.
30. [30] Fox, P.L., The copper-iron chronicles: the story of an intimate relationship. Biometals 16 (2003), 9–40.
31. [31] Sharp, P., The molecular basis of copper and iron interactions. Proc. Nutr. Soc. 63 (2004), 563–569.
32. 59Fe absorption in duodenum and ileum in vivo. Toxicology 284 (2011), 7–11.
33. [33] Shah, F., Kazi, T.G., Afridi, H.I., Baig, J.A., Khan, S., Kolachi, N.F., Wadhwa, S.K., Shah, A.Q., Environmental exposure of lead and iron deficit anemia in children age ranged 1–5 years: a cross sectional study. Sci. Total Environ. 408 (2010), 5325–5330.
34. [34] Aschner, J.L., Aschner, M., Nutritional aspects of manganese homeostasis. Mol. Asp. Med. 26 (2005), 353–362.
35. [35] Avila, D.S., Puntel, R.L., Aschner, M., Manganese in health and disease. Met. Ions Life Sci. 13 (2013), 199–227, 10.1007/978-94-007-7500-8_7.
36. [36] Crossgrove, J., Zheng, W., Manganese toxicity upon overexposure. NMR Biomed. 17 (2004), 544–553.
37. [37] Roth, J.A., Garrick, M.D., Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem. Pharmacol. 66 (2003), 1–13.
38. [38] Gunshin, H., Mackenzie, B., Berger, U.V., Gunshin, Y., Romero, M.F., Boron, W.F., Nussberger, S., Gollan, J.L., Hediger, M.A., Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388 (1997), 482–488.
39. [39] Garrick, M.D., Dolan, K.G., An expression system for a transporter of iron and other metals. Methods Mol. Biol. 196 (2002), 147–154.
40. [40] Garrick, M.D., Singleton, S.T., Vargas, F., Kuo, H.C., Zhao, L., Knöpfel, M., Davidson, T., Costa, M., Paradkar, P., Roth, J.A., Garrick, L.M., DMT1: which metals does it transport?. Biol. Res. 39 (2006), 79–85.
41. [41] Bannon, D.I., Abounader, R., Lees, P.S., Bressler, J.P., Effect of DMT1 knockdown on iron cadmium, and lead uptake in Caco-2 cells. Am. J. Physiol. Cell Physiol. 284 (2003), C44–C50.
42. [42] Wang, X., Li, G.J., Zheng, W., Upregulation of DMT1 expression in choroidal epithelia of the blood—CSF barrier following manganese exposure in vitro. Brain Res. 1097 (2006), 1–10.
43. [43] Au, C., Benedetto, A., Aschner, M., Manganese transport in eukaryotes: the role of DMT1. Neurotoxicology 29 (2008), 569–576.
44. [44] Heilig, E.A., Thompson, K.J., Molina, R.M., Ivanov, A.R., Brain, J.D., Wessling-Resnick, M., Manganese and iron transport across pulmonary epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 290 (2006), L1247–L1259.
45. [45] Yin, Z., Jiang, H., Lee, E.S., Ni, M., Erikson, K.M., Milatovic, D., Bowman, A.B., Aschner, M., Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J. Neurochem. 112 (2010), 1190–1198.
46. [46] Madejczyk, M.S., Ballatori, N., The iron transporter ferroportin can also function as a manganese exporter. Biochim. Biophys. Acta 1818 (2012), 651–657.
47. [47] Mitchell, C.J., Shawki, A., Ganz, T., Nemeth, E., Mackenzie, B., Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc. Am. J. Physiol. Cell Physiol. 306 (2014), C450–C459.
48. [48] Park, B.Y., Chung, J., Effects of various metal ions on the gene expression of iron exporter ferroportin-1 in J774 macrophages. Nutr. Res. Pract. 2 (2008), 317–321.
49. [49] Aisen, P., Aasa, R., Redfield, A.G., The chromium manganese, and cobalt complexes of transferrin. J. Biol. Chem. 244 (1969), 4628–4633.
50. [50] Gkouvatsos, K., Papanikolaou, G., Pantopoulos, K., Regulation of iron transport and the role of transferrin. Biochim. Biophys. Acta 1820 (2012), 188–202.
51. [51] Harris, W.R., Chen, Y., Electron paramagnetic resonance and difference ultraviolet studies of Mn2+ binding to serum transferrin. J. Inorg. Biochem. 54 (1994), 1–19.
52. [52] Vincent, J.B., Love, S., The binding and transport of alternative metals by transferrin. Biochim. Biophys. Acta 1820 (2012), 362–378.
53. [53] Aschner, M., Vrana, K.E., Zheng, W., Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology 20 (1998), 173–180.
54. [54] Gunter, T.E., Gerstner, B., Gunter, K.K., Malecki, J., Gelein, R., Valentine, W.M., Aschner, M., Yule, D.I., Manganese transport via the transferrin mechanism. Neurotoxicology 34 (2013), 118–127.
55. [55] Moshtaghi, A.A., Badiei, A., Hasanzadeh, T., Role of ceruloplasmin and ethanolamine in manganese binding to human serum apo-transferrin. Iran. J. Sci. Technol. B 21 (1997), 157–168.
56. [56] Hellman, N.E., Gitlin, J.D., Ceruloplasmin metabolism and function. Annu. Rev. Nutr. 22 (2002), 439–458.
57. [57] Critchfield, J.W., Keen, C.L., Manganese+ 2 exhibits dynamic binding to multiple ligands in human plasma. Metabolism 41 (1992), 1087–1092.
58. [58] Roth, J.A., Garrick, M.D., Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem. Pharmacol. 66 (2003), 1–13.
59. [59] Pantopoulos, K., Iron metabolism and the IRE/IRP regulatory system: an update. Ann. N. Y. Acad. Sci. 1012 (2004), 1–13.
60. [60] Kwik-Uribe, C.L., Reaney, S., Zhu, Z., Smith, D., Alteratio ns in cellular IRP-dependent iron regulation by in vitro manganese exposure in undifferentiated PC12 cells. Brain Res. 973 (2003), 1–15.
61. [61] Kwik-Uribe, C., Smith, D.R., Temporal responses in the disruption of iron regulation by manganese. J. Neurosci. Res. 83 (2006), 1601–1610.
62. [62] Crooks, D.R., Ghosh, M.C., Braun-Sommargren, M., Rouault, T.A., Smith, D.R., Manganese targets m-aconitase and activates iron regulatory protein 2 in AF5 GABAergic cells. J. Neurosci. Res. 85 (2007), 1797–1809.
63. [63] Oshiro, S., Nozawa, K., Hori, M., Zhang, C., Hashimoto, Y., Kitajima, S., Kawamura, K.I., Modulation of iron regulatory protein-1 by various metals. Biochem. Biophys. Res. Commun. 290 (2002), 213–218.
64. [64] Bartnikas, T.B., Known and potential roles of transferrin in iron biology. Biometals 25 (2012), 677–686.
65. [65] Garcia, S.J., Gellein, K., Syversen, T., Aschner, M., A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol. Sci. 92 (2006), 516–525.
66. [66] Thompson, K., Molina, R.M., Donaghey, T., Schwob, J.E., Brain, J.D., Wessling-Resnick, M., Olfactory uptake of manganese requires DMT1 and is enhanced by anemia. FASEB J. 21 (2007), 223–230.
67. [67] Shawki, A., Anthony, S.R., Nose, Y., Engevik, M.A., Niespodzany, E.J., Barrientos, T., Öhrvik, H., Worrell, R.T., Thiele, D.J., Mackenzie, B., Intestinal DMT1 is critical for iron absorption in the mouse but is not required for the absorption of copper or manganese. Am. J. Physiol. Gastrointest. Liver Physiol. 309 (2015), G635–G647, 10.1152/ajpgi.00160.2015.
68. [68] Crossgrove, J.S., Yokel, R.A., Manganese distribution across the blood–brain barrier III. The divalent metal transporter-1 is not the major mechanism mediating brain manganese uptake. Neurotoxicology 25 (2004), 451–460.
69. [69] Seo, Y.A., Wessling-Resnick, M., Ferroportin deficiency impairs manganese metabolism in flatiron mice. FASEB J. 29 (2015), 2726–2733.
70. [70] Seo, Y.A., Elkhader, J.A., Wessling-Resnick, M., Distribution of manganese and other biometals in flatiron mice. Biometals 29 (2016), 147–155.
71. [71] Kim, J., Buckett, P.D., Wessling-Resnick, M., Absorption of manganese and iron in a mouse model of hemochromatosis. PLoS One, 8, 2013, e64944, 10.1371/journal.pone.0064944.
72. [72] Jouihan, H.A., Cobine, P.A., Cooksey, R.C., Hoagland, E.A., Boudina, S., Abel, E.D., Winge, D.R., McClain, D.A., Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis. Mol. Med. 14 (2008), 98–108.
73. [73] Pang, L., Wang, J., Huang, W., Guo, S., A study of divalent metal transporter 1 and ferroportin 1 in brain of rats with manganese-induced parkinsonism (in Chinese). Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 33 (2015), 250–254.
74. [74] Davidsson, L., Lönnerdal, B., Sandström, B., Kunz, C., Keen, C.L., Identification of transferrin as the major plasma carrier protein for manganese introduced orally or intravenously or after in vitro addition in the rat. J. Nutr. 119 (1989), 1461–1464.
75. [75] Dickinson, T.K., Devenyi, A.G., Connor, J.R., Distribution of injected iron 59 and manganese 54 in hypotransferrinemic mice. J. Lab. Clin. Med. 128 (1996), 270–278.
76. [76] Herrera, C., Pettiglio, M.A., Bartnikas, T.B., Investigating the role of transferrin in the distribution of iron manganese, copper, and zinc. J. Biol. Inorg. Chem. 19 (2014), 869–877.
77. [77] Moutafchiev, D., Sirakov, L., Bontchev, P., The competition between transferrins labeled with 59Fe 65Zn, and 54 Mn for the binding sites on lactating mouse mammary gland cells. Biol. Trace Elem. Res. 61 (1998), 181–191.
78. [78] Chandra, S.V., Shukla, G.S., Role of iron deficiency in inducing susceptibility to manganese toxicity. Arch. Toxicol. 35 (1976), 319–323.
79. [79] Heilig, E., Molina, R., Donaghey, T., Brain, J.D., Wessling-Resnick, M., Pharmacokinetics of pulmonary manganese absorption: evidence for increased susceptibility to manganese loading in iron-deficient rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005), L887–L893.
80. [80] Thompson, K., Molina, R., Donaghey, T., Brain, J.D., Wessling-Resnick, M., The influence of high iron diet on rat lung manganese absorption. Toxicol. Appl. Pharmacol. 210 (2006), 17–23.
81. [81] Vayenas, D.V., Repanti, M., Vassilopoulos, A., Papanastasiou, D.A., Influence of iron overload on manganese, zinc, and copper concentration in rat tissues in vivo: study of liver, spleen, and brain. Int. J. Clin. Lab. Res. 28 (1998), 183–186.
82. [82] Zheng, W., Zhao, Q., Slavkovich, V., Aschner, M., Graziano, J.H., Alteration of iron homeostasis following chronic exposure to manganese in rats. Brain Res. 833 (1999), 125–132.
83. [83] Hansen, S.L., Ashwell, M.S., Moeser, A.J., Fry, R.S., Knutson, M.D., Spears, J.W., High dietary iron reduces transporters involved in iron and manganese metabolism and increases intestinal permeability in calves. J. Dairy Sci. 93 (2010), 656–665.
84. [84] Park, S., Sim, C.S., Lee, H., Kim, Y., Blood manganese concentration is elevated in infants with iron deficiency. Biol. Trace Elem. Res. 155 (2013), 184–189.
85. [85] Kim, Y., Park, J.K., Choi, Y., Yoo, C.I., Lee, C.R., Lee, H., Lee, J.H., Kim, S.R., Jeong, T.H., Yoon, C.S., Park, J.H., Blood manganese concentration is elevated in iron deficiency anemia patients, whereas globus pallidus signal intensity is minimally affected. Neurotoxicology 26 (2005), 107–111.
86. [86] Smith, E.A., Newland, P., Bestwick, K.G., Ahmed, N., Increased whole blood manganese concentrations observed in children with iron deficiency anaemia. J. Trace Elem. Med. Biol. 27 (2013), 65–69.
87. [87] Kim, Y., Lee, B.K., Iron deficiency increases blood manganese level in the Korean general population according to KNHANES 2008. Neurotoxicology 32 (2011), 247–254.
88. [88] Meltzer, H.M., Brantsæter, A.L., Borch-Iohnsen, B., Ellingsen, D.G., Alexander, J., Thomassen, Y., Stigum, H., Ydersbond, T.A., Low iron stores are related to higher blood concentrations of manganese, cobalt and cadmium in non-smoking Norwegian women in the HUNT 2 study. Environ. Res. 110 (2010), 497–504.
89. [89] Brna, P., Gordon, K., Dooley, J.M., Price, V., Manganese toxicity in a child with iron deficiency and polycythemia. J. Child Neurol. 26 (2011), 891–894.
90. [90] Claus Henn, B., Kim, J., Wessling-Resnick, M., Téllez-Rojo, M.M., Jayawardene, I., Ettinger, A.S., Hernández-Avila, M., Schwartz, J., Christiani, D.C., Hu, H., Wright, R.O., Associations of iron metabolism genes with blood manganese levels: a population-based study with validation data from animal models. Environ. Health, 10, 2011, 97, 10.1186/1476-069X-10-97.
91. [91] Cowan, D.M., Fan, Q., Zou, Y., Shi, X., Chen, J., Aschner, M., Rosenthal, F.S., Zheng, W., Manganese exposure among smelting workers: blood manganese-iron ratio as a novel tool for manganese exposure assessment. Biomarkers 14 (2009), 3–16.
92. [92] Pesch, B., Weiss, T., Kendzia, B., Henry, J., Lehnert, M., Lotz, A., Heinze, E., Käfferlein, H.U., Van Gelder, R., Berges, M., Hahn, J.U., Mattenklott, M., Punkenburg, E., Hartwig, A., Hahn, J.U., Levels and predictors of airborne and internal exposure to manganese and iron among welders. J. Expo. Sci. Environ. Epidemiol. 22 (2012), 291–298.
93. [93] Lu, L., Zhang, L.L., Li, G.J., Guo, W., Liang, W., Zheng, W., Alteration of serum concentrations of manganese, iron, ferritin, and transferrin receptor following exposure to welding fumes among career welders. Neurotoxicology 26 (2005), 257–265.
94. [94] Ellingsen, D.G., Haug, E., Ulvik, R.J., Thomassen, Y., Iron status in manganese alloy production workers. J. Appl. Toxicol. 23 (2003), 239–247.
95. [95] Tholin, K., Sandström, B., Palm, R., Hallmans, G., Changes in blood manganese levels during pregnancy in iron supplemented and non supplemented women. J. Trace Elem. Med. Biol. 9 (1995), 13–17.
96. [96] Finley, J.W., Manganese absorption and retention by young women is associated with serum ferritin concentration. Am. J. Clin. Nutr. 70 (1999), 37–43.
97. [97] Davis, C.D., Malecki, E.A., Greger, J.L., Interactions among dietary manganese heme iron, and nonheme iron in women. Am. J. Clin. Nutr. 56 (1992), 926–932.
98. [98] Davis, C.D., Greger, J.L., Longitudinal changes of manganese-dependent superoxide dismutase and other indexes of manganese and iron status in women. Am. J. Clin. Nutr. 55 (1992), 747–752.
99. [99] Erikson, K.M., Syversen, T., Aschner, J.L., Aschner, M., Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration. Environ. Toxicol. Pharmacol. 19 (2005), 415–421.
100. [100] Prasad, A.S., Clinical immunological, anti-inflammatory and antioxidant roles of zinc. Exp. Gerontol. 43 (2008), 370–377.
101. [101] Prasad, A.S., Kucuk, O., Zinc in cancer prevention. Cancer Metastasis Rev. 21 (2002), 291–295.
102. [102] Levenson, C.W., Zinc supplementation: neuroprotective or neurotoxic?. Nutr. Rev. 63 (2005), 122–125.
103. [103] Maret, W., Sandstead, H.H., Zinc requirements and the risks and benefits of zinc supplementation. J. Trace Elem. Med. Biol. 20 (2006), 3–18.
104. [104] Prasad, A.S., Discovery of human zinc deficiency: its impact on human health and disease. Adv. Nutr. 4 (2013), 176–190.
105. [105] Plum, L.M., Rink, L., Haase, H., The essential toxin: impact of zinc on human health. Int. J. Environ. Res. Publ. Health 7 (2010), 1342–1365.
106. [106] Underwood, E.J., Trace Elements in Human and Animal Nutrition. 4th ed., 1977, Academic Press, New York.
107. [107] Solomons, N.W., Ruz, M., Zinc and iron interaction: concepts and perspectives in the developing world. Nutr. Res. 17 (1997), 177–185.
108. [108] Cousins, R.J., Liuzzi, J.P., Lichten, L.A., Mammalian zinc transport trafficking, and signals. J. Biol. Chem. 281 (2006), 24085–24089.
109. [109] Murakami, M., Hirano, T., Intracellular zinc homeostasis and zinc signaling. Cancer Sci. 99 (2008), 1515–1522.
110. [110] Garrick, M.D., Human iron transporters. Genes Nutr. 6 (2011), 45–54.
111. [111] Liuzzi, J.P., Aydemir, F., Nam, H., Knutson, M.D., Cousins, R.J., Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 13612–13617.
112. [112] Iyengar, V., Pullakhandam, R., Nair, K.M., Coordinate expression and localization of iron and zinc transporters explain iron-zinc interactions during uptake in Caco-2 cells: implications for iron uptake at the enterocyte. J. Nutr. Biochem. 23 (2012), 1146–1154.
113. [113] Wang, C.Y., Jenkitkasemwong, S., Duarte, S., Sparkman, B.K., Shawki, A., Mackenzie, B., Knutson, M.D., ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading. J. Biol. Chem. 287 (2012), 34032–34043.
114. [114] Illing, A.C., Shawki, A., Cunningham, C.L., Mackenzie, B., Substrate profile and metal-ion selectivity of human divalent metal-ion transporter-1. J. Biol. Chem. 287 (2012), 30485–30496.
115. [115] Yamaji, S., Tennant, J., Tandy, S., Williams, M., Singh Srai, S.K., Sharp, P., Zinc regulates the function and expression of the iron transporters DMT1 and IREG1 in human intestinal Caco-2 cells. FEBS Lett. 507 (2001), 137–141.
116. [116] Rouault, T.A., The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nature Chem. Biol. 2 (2006), 406–414.
117. [117] Martelli, A., Moulis, J.M., Zinc and cadmium specifically interfere with RNA-binding activity of human iron regulatory protein 1. J. Inorg. Biochem. 98 (2004), 1413–1420.
118. [118] Niles, B.J., Clegg, M.S., Hanna, L.A., Chou, S.S., Momma, T.Y., Hong, H., Keen, C.L., Zinc deficiency-induced iron accumulation a consequence of alterations in iron regulatory protein-binding activity, iron transporters, and iron storage proteins. J. Biol. Chem. 283 (2008), 5168–5177.
119. [119] Ganz, T., Hepcidin a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 (2003), 783–788.
120. [120] Balesaria, S., Ramesh, B., McArdle, H., Bayele, H.K., Srai, S.K., Divalent metal-dependent regulation of hepcidin expression by MTF-1. FEBS Lett. 584 (2010), 719–725.
121. [121] Graham, R.D., Knez, M., Welch, R.M., How much nutritional iron deficiency in humans globally is due to an underlying zinc deficiency?. Adv. Agron. 115 (2012), 1–40.
122. [122] Arredondo, M., Martinez, R., Nunez, M.T., Ruz, M., Olivares, M., Inhibition of iron and copper uptake by iron, copper and zinc. Biol. Res. 39 (2006), 95–102.
123. [123] Iyengar, V., Pullakhandam, R., Nair, K.M., Iron-zinc interaction during uptake in human intestinal Caco-2 cell line: kinetic analyses and possible mechanism. Indian J. Biochem. Biophys. 46 (2009), 299–306.
124. [124] Kelleher, S.L., Lönnerdal, B., Zinc supplementation reduces iron absorption through age-dependent changes in small intestine iron transporter expression in suckling rat pups. J. Nutr. 136 (2006), C1185–C1191.
125. [125] Shoham, S., Youdim, M.B., The effects of iron deficiency and iron and zinc supplementation on rat hippocampus ferritin. J. Neural Transm. (Vienna) 109 (2002), 1241–1256.
126. [126] Yokoi, K., Kimura, M., Itokawa, Y., Effect of dietary iron deficiency on mineral levels in tissues of rats. Biol. Trace Elem. Res. 29 (1991), 257–265.
127. [127] Nam, H., Knutson, M.D., Effect of dietary iron deficiency and overload on the expression of ZIP metal-ion transporters in rat liver. Biometals 25 (2012), 115–124.
128. [128] Yanagisawa, H., Miyakoshi, Y., Kobayashi, K., Sakae, K., Kawasaki, I., Suzuki, Y., Tamura, J., Long-term intake of a high zinc diet causes iron deficiency anemia accompanied by reticulocytosis and extra-medullary erythropoiesis. Toxicol. Lett. 191 (2009), 15–19.
129. [129] Rogers, J.M., Lönnerdal, B., Hurley, L.S., Keen, C.L., Iron and zinc concentrations and 59Fe retention in developing fetuses of zinc-deficient rats. J. Nutr. 117 (1987), 1875–1882.
130. [130] Gómez-Ayala, A.E., Lisbona, F., López-Aliaga, I., Pallarés, I., Barrionuevo, M., Hartiti, S., Rodríguez-Matas, M.C., Campos, M.S., The absorption of iron calcium, phosphorus, magnesium, copper and zinc in the jejunum-ileum of control and iron-deficient rats. Lab. Anim. 32 (1998), 72–79.
131. [131] Konomi, A., Yokoi, K., Zinc deficiency decreases plasma erythropoietin concentration in rats. Biol. Trace Elem. Res. 107 (2005), 289–292.
132. [132] Konomi, A., Yokoi, K., Changes of erythropoietin concentrations in plasma and kidney induced by zinc deficiency in rats. FASEB J., 24(Suppl), 2010, 718.2.
133. [133] Ece, A., Uyanik, B.S., Işcan, A., Ertan, P., Yiğitoğlu, M.R., Increased serum copper and decreased serum zinc levels in children with iron deficiency anemia. Biol. Trace Elem. Res. 59 (1997), 31–39.
134. [134] Gürgöze, M.K., Ölçücü, A., Aygün, A.D., Taşkin, E., Kiliç, M., Serum and hair levels of zinc selenium, iron, and copper in children with iron-deficiency anemia. Biol. Trace Elem. Res. 111 (2006), 23–29.
135. [135] Turgut, S., Polat, A., Inan, M., Turgut, G., Emmungil, G., Bican, M., Karakus, T.Y., Genc, O., Interaction between anemia and blood levels of iron zinc, copper, cadmium and lead in children. Indian J. Pediatr. 74 (2007), 827–830.
136. [136] Hegazy, A.A., Zaher, M.M., Abd El-Hafez, M.A., Morsy, A.A., Saleh, R.A., Relation between anemia and blood levels of lead, copper, zinc and iron among children. BMC Res. Notes, 3, 2010, 133, 10.1186/1756-0500-3-133.
137. [137] Alarcon, K., Kolsteren, P.W., Prada, A.M., Chian, A.M., Velarde, R.E., Pecho, I.L., Hoeree, T.F., Effects of separate delivery of zinc or zinc and vitamin A on hemoglobin response growth, and diarrhea in young Peruvian children receiving iron therapy for anemia. Am. J. Clin. Nutr. 80 (2004), 1276–1282.
138. [138] Kolsteren, P., Rahman, S.R., Hilderbrand, K., Diniz, A., Treatment for iron deficiency anaemia with a combined supplementation of iron vitamin A and zinc in women of Dinajpur, Bangladesh. Eur. J. Clin. Nutr. 53 (1999), 102–106.
139. [139] Nishiyama, S., Kiwaki, K., Miyazaki, Y., Hasuda, T., Zinc and IGF-I concentrations in pregnant women with anemia before and after supplementation with iron and/or zinc. J. Am. Coll. Nutr. 18 (1999), 261–267.
140. [140] O'Brien, K.O., Zavaleta, N., Caulfield, L.E., Yang, D.X., Abrams, S.A., Influence of prenatal iron and zinc supplements on supplemental iron absorption red blood cell iron incorporation, and iron status in pregnant Peruvian women. Am. J. Clin. Nutr. 69 (1999), 509–515.
141. [141] O'Brien, K.O., Zavaleta, N., Caulfield, L.E., Wen, J., Abrams, S.A., Prenatal iron supplements impair zinc absorption in pregnant Peruvian women. J. Nutr. 130 (2000), 2251–2255.
142. [142] Chung, C.S., Nagey, D.A., Veillon, C., Patterson, K.Y., Jackson, R.T., Moser-Veillon, P.B., A single 60-mg iron dose decreases zinc absorption in lactating women. J. Nutr. 132 (2002), 1903–1905.
143. [143] Troost, F.J., Brummer, R.J., Dainty, J.R., Hoogewerff, J.A., Bull, V.J., Saris, W.H., Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects. Am. J. Clin. Nutr. 78 (2003), 1018–1023.
144. [144] Crofton, R.W., Gvozdanovic, D., Gvozdanovic, S., Khin, C.C., Brunt, P.W., Mowat, N.A., Aggett, P.J., Inorganic zinc and the intestinal absorption of ferrous iron. Am. J. Clin. Nutr. 50 (1989), 141–144.
145. [145] Rossander-Hulten, L., Brune, M., Sandström, B., Lönnerdal, B., Hallberg, L., Competitive inhibition of iron absorption by manganese and zinc in humans. Am. J. Clin. Nutr. 54 (1991), 152–156.
146. [146] Davidson, L., Almgren, A., Sandström, B., Hurrell, R.F., Zinc absorption in adult humans: the effect of iron fortification. Br. J. Nutr. 74 (1995), 417–425.
147. [147] Fairweather-Tait, S.J., Wharf, S.G., Fox, T.E., Zinc absorption in infants fed iron-fortified weaning food. Am. J. Clin. Nutr. 62 (1995), 785–789.
148. [148] Davidsson, L., Kastenmayer, P., Hurrell, R.F., Sodium iron EDTA [NaFe (III) EDTA] as a food fortificant: the effect on the absorption and retention of zinc and calcium in women. Am. J. Clin. Nutr. 60 (1994), 231–237.
149. [149] Yip, R., Reeves, J.D., Lönnerdal, B., Keen, C.L., Dallman, P., Does iron supplementation compromise zinc nutrition in healthy infants?. Am. J. Clin. Nutr. 42 (1985), 683–687.
150. [150] Domellöf, M., Hernell, O., Abrams, S.A., Chen, Z., Lönnerdal, B., Iron supplementation does not affect copper and zinc absorption in breastfed infants. Am. J. Clin. Nutr. 89 (2009), 185–190.
151. [151] Harvey, L.J., Dainty, J.R., Hollands, W.J., Bull, V.J., Hoogewerff, J.A., Foxall, R.J., McAnena, L., Strain, J.J., Fairweather-Tait, S.J., Effect of high-dose iron supplements on fractional zinc absorption and status in pregnant women. Am. J. Clin. Nutr. 85 (2007), 131–136.
152. [152] de Romaña, D.L., Ruz, M., Pizarro, F., Landeta, L., Olivares, M.A., Supplementation with zinc between meals has no effect on subsequent iron absorption or on iron status of Chilean women. Nutrition 24 (2008), 957–963.
153. [153] Olivares, M., Pizarro, F., Ruz, M., New insights about iron bioavailability inhibition by zinc. Nutrition 23 (2007), 292–295.
154. [154] Olivares, M., Pizarro, F., Gaitán, D., Ruz, M., Acute inhibition of iron absorption by zinc. Nutr. Res. 27 (2007), 279–282.
155. [155] Solomons, N.W., Jacob, R.A., Studies on the bioavailability of zinc in humans: effects of heme and nonheme iron on the absorption of zinc. Am. J. Clin. Nutr. 34 (1981), 475–482.
156. [156] Pérès, J.M., Bureau, F., Neuville, D., Arhan, P., Bouglé, D., Inhibition of zinc absorption by iron depends on their ratio. J. Trace Elem. Med. Biol. 15 (2001), 237–241.
157. [157] Olivares, M., Hertrampf, E., Uauy, R., Copper and zinc interactions in anemia: a public health perspective. Kraemer, K., Zimmermann, M.B., (eds.) Nutritional Anemia, 2007, Sight and Life Press, Basel, 99–109.
158. [158] Vincent, J.B., The Bioinorganic Chemistry of Chromium. 2013, John Wiley & Sons, Chichester.
159. [159] San, H., Brokato, J., Costa, M., Oral chromium exposure and toxicity. Curr. Environ. Health Rep. 2 (2015), 295–303.
160. [160] Kazi, T.G., Afridi, H.I., Kazi, N., Jamali, M.K., Arain, M.B., Jalbani, N., Kandhro, G.A., Copper chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol. Trace Elem. Res. 122 (2008), 1–18.
161. [161] Pechova, A., Pavlata, L., Chromium as a essential nutrient: a review. Vet. Med. (Praha) 52 (2007), 1–18.
162. [162] Laschinsky, N., Kottwitz, K., Freund, B., Dresow, B., Fischer, R., Nielsen, P., Bioavailability of chromium(III)-supplements in rats and humans. Biometals 25 (2012), 1051–1060.
163. [163] Moshtaghie, A.A., Ani, M., Bazrafshan, M.R., Comparative binding study of aluminum and chromium to human transferrin. Biol. Trace Elem. Res. 32 (1992), 39–46.
164. [164] Ani, M., Moshtaghie, A.A., The effect of chromium on parameters related to iron metabolism. Biol. Trace Elem. Res. 32 (1992), 57–64.
165. [165] Lukaski, H.C., Bolonchuk, W.W., Siders, W.A., Milne, D.B., Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am. J. Clin. Nutr. 63 (1996), 954–965.
166. [166] Boyd, S.G., Boone, B.E., Smith, A.R., Conners, J., Dohm, G.L., Combined dietary chromium picolinate and an exercise program leads to a reduction in serum cholesterol and insulin in college-aged subjects. J. Nutr. Biochem. 9 (1998), 471–475.
167. [167] Chen, T.S., Chen, Y.T., Liu, C.H., Sun, C.C., Mao, F.C., Effect of chromium supplementation on element distribution in a mouse model of polycystic ovary syndrome. Biol. Trace Elem. Res. 168 (2015), 472–480.
168. [168] Prescha, A., Krzysik, M., Zablocka-Slowinska, K., Grajeta, H., Effects of exposure to dietary chromium on tissue mineral contents in rats fed diets with fiber. Biol. Trace Elem. Res. 159 (2014), 325–331.
169. [169] Dogukan, A., Sahin, N., Tuzcu, M., Juturu, V., Orhan, C., Onderci, M., Komorowski, J., Sahin, K., The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats. Biol. Trace Elem. Res. 131 (2009), 124–132.
170. [170] Król, E., Krejpcio, Z., Dietary chromium(III) propionate complex supplementation affects tissue mineral levels in rats fed high-fructose diet. J. Elem. 18 (2013), 91–98, 10.5601/jelem.2013.18.1.07.
171. [171] Kumar, M., Kaur, H., Tyagi, A., Mani, V., Sarma, R., Chandra, G., Sharma, V.K., Assessment of chromium content of feedstuffs their estimated requirement, and effects of dietary chromium supplementation on nutrient utilization growth performance, and mineral balance in summer-exposed Buffalo Calves (Bubalus bubalis). Biol. Trace Elem. Res. 155 (2013), 29–37.
172. [172] Kucukbay, F.Z., Yazlak, H., Sahin, N., Cakmak, M.N., Effects of dietary chromium picolinate supplementation on serum glucose, cholesterol and minerals of rainbow trout (Oncorhynchus mykiss). Acquaint Int. 14 (2006), 259–266.
173. [173] Krol, E., Krejpcio, Z., Evaluation of anti-diabetic potential of chromium(III) propionate complex in high-fat diet fed and STZ injected rats. Food Chem. Toxicol. 49 (2011), 3217–3223.
174. [174] Tinkov, A.A., Polyakova, V.S., Nikonorov, A.A., Chronic administration of iron and copper potentiates adipogenic effect of high fat diet in Wistar rats. Biometals 26 (2013), 447–463.
175. [175] Angelova, M.G., Petkova-Marinova, T.V., Pogorielov, M.V., Loboda, A.N., Nedkova-Kolarova, V.N., Bozhinova, A.N., Trace element status (iron, zinc, copper, chromium, cobalt, and nickel) in iron-deficiency anaemia of children under 3 years. Anemia, 2014, 2014, 718089, 10.1155/2014/718089.
176. [176] Campbell, W.W., Beard, J.L., Joseph, L.J., Davey, S.L., Evans, W.J., Chromium picolinate supplementation and resistive training by older men: effects on iron status and hematological indices. Am. J. Clin. Nutr. 66 (1997), 944–949.
177. [177] Basaki, M., Saeb, M., Nazifi, S., Shamsaei, H.A., Zinc copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus. Biol. Trace Elem. Res. 148 (2012), 161–164.
178. [178] Van Bokhoven, M.A., van Deursen, C.T., Swinkels, D.W., Diagnosis and management of hereditary haemochromatosis. BMJ, 342, 2011, c7251.
179. [179] Olynyk, J.K., Cullen, D.J., Aquilia, S., Rossi, E., Summerville, L., Powell, L.W., A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 341 (1990), 718–724.
180. [180] Distante, S., Robson, K.J., Graham-Campbell, J., Arnaiz-Villena, A., Brissot, P., Worwood, M., The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum. Genet. 115 (2004), 269–279.
181. [181] Gordeuk, V., Boyd, R.D., Brittenham, G., Dietary iron overload persists in rural sub-Saharan Africa. Lancet 327 (1986), 1310–1313.
182. [182] Chelation Therapy in the Treatment of Metal Intoxication. Aaseth, J., Crisponi, G., Andersen, O., (eds.), 2016, Academic Press, London.
183. [183] Stevens, R.G., Jones, D.Y., Micozzi, M.S., Taylor, P.R., Body iron stores and the risk of cancer. N. Eng. J. Med. 319 (1988), 1047–1052.
184. [184] Aaseth, J., Flaten, T.P., Andersen, O., Hereditary iron and copper deposition: diagnostics, pathogenesis, and therapeutics. Scand. J. Gastroenterol. 42 (2007), 673–681.
185. [185] Halliwell, B., Chirico, S., Lipid peroxidation: its mechanism measurement, and significance. Am. J. Clin. Nutr. 57 (1993), 715S–724S.
186. [186] Herbert, V., Shaw, S., Jayatilleke, E., Vitamin C-driven free radical generation from iron. J. Nutr., 126, 1996, 1213S.
187. [187] Gülsan, M., Malbora, B., Avci, Z., Bayraktar, N., Bozkaya, I., Ozbek, N., Effects of zinc sulfate supplementation in treatment of iron deficiency anemia. Turk. J. Haematol. 30 (2013), 144–1452.